Literature DB >> 21973272

Obesity and allometric scaling of pharmacokinetics.

Douglas J Eleveld1, Johannes H Proost, Anthony R Absalom, Michel M R F Struys.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21973272     DOI： 10.2165/11594080-000000000-00000

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  14 in total

Review 1.  Dose adjustment of anaesthetics in the morbidly obese.

Authors:  J Ingrande; H J M Lemmens
Journal:  Br J Anaesth       Date:  2010-12       Impact factor: 9.166

2.  Total intravenous anaesthesia to obese patients: largely guesswork?

Authors:  Johan F Coetzee
Journal:  Eur J Anaesthesiol       Date:  2009-05       Impact factor: 4.330

3.  No adjustment vs. adjustment formula as input weight for propofol target-controlled infusion in morbidly obese patients.

Authors:  Luca La Colla; Andrea Albertin; Giorgio La Colla; Valerio Ceriani; Tiziana Lodi; Andrea Porta; Giorgio Aldegheri; Alberto Mangano; Ilias Khairallah; Isabella Fermo
Journal:  Eur J Anaesthesiol       Date:  2009-05       Impact factor: 4.330

4.  Pharmacokinetic model-driven remifentanil administration in the morbidly obese: the 'critical weight' and the 'fictitious height', a possible solution to an unsolved problem?

Authors:  L La Colla; A Albertin; G La Colla
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model.

Authors:  Mariska Y M Peeters; Karel Allegaert; Heleen J Blussé van Oud-Alblas; Massimo Cella; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

6.  Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects.

Authors:  Jerry Ingrande; Jay B Brodsky; Hendrikus J M Lemmens
Journal:  Anesth Analg       Date:  2010-09-22       Impact factor: 5.108

7.  Comparative evaluation of propofol 350 and 200 mg for induction of anaesthesia in morbidly obese patients: a randomized double-blind pilot study.

Authors:  Simone van Kralingen; Jeroen Diepstraten; Ewoudt M W van de Garde; Ary-Jan van der Lely; Eric P A van Dongen; Bert van Ramshorst; Catherijne A J Knibbe
Journal:  Eur J Anaesthesiol       Date:  2010-06       Impact factor: 4.330

8.  Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model.

Authors:  L I Cortínez; B J Anderson; A Penna; L Olivares; H R Muñoz; N H G Holford; M M R F Struys; P Sepulveda
Journal:  Br J Anaesth       Date:  2010-08-14       Impact factor: 9.166

9.  Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study.

Authors:  F Servin; R Farinotti; J P Haberer; J M Desmonts
Journal:  Anesthesiology       Date:  1993-04       Impact factor: 7.892

Review 10.  Effect of obesity on the pharmacokinetics of drugs in humans.

Authors:  Michael J Hanley; Darrell R Abernethy; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447
View more
  14 in total

1.  Levobupivacaine absorption pharmacokinetics with and without epinephrine during TAP block: analysis of doses based on the associated risk of local anaesthetic toxicity.

Authors:  P Miranda; M A Corvetto; Fernando R Altermatt; A Araneda; G C Echevarría; L I Cortínez
Journal:  Eur J Clin Pharmacol       Date:  2016-07-14       Impact factor: 2.953

Review 2.  A Review of the Methods and Associated Mathematical Models Used in the Measurement of Fat-Free Mass.

Authors:  Jaydeep Sinha; Stephen B Duffull; Hesham S Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2018-07       Impact factor: 6.447

3.  Propofol Clearance in Morbidly Obese Children and Adolescents : Influence of Age and Body Size.

Authors:  Jeroen Diepstraten; Vidya Chidambaran; Senthilkumar Sadhasivam; Hope R Esslinger; Shareen L Cox; Thomas H Inge; Catherijne A J Knibbe; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2012-08       Impact factor: 6.447

4.  Evaluating the Relationship Between Lean Liver Volume and Fat-Free Mass.

Authors:  Jaydeep Sinha; Stephen B Duffull; Bruce Green; Hesham S Al-Sallami
Journal:  Clin Pharmacokinet       Date:  2020-04       Impact factor: 6.447

5.  Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint.

Authors:  Jeroen Diepstraten; Esther J H Janssen; Christian M Hackeng; Eric P A van Dongen; René J Wiezer; Bert van Ramshorst; Catherijne A J Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2014-10-12       Impact factor: 2.953

6.  Pharmacokinetics of Anidulafungin in Obese and Normal-Weight Adults.

Authors:  Roeland E Wasmann; Rob Ter Heine; Eric P van Dongen; David M Burger; Vincent J Lempers; Catherijne A Knibbe; Roger J Brüggemann
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

7.  Population Pharmacokinetic Modelling of Acetaminophen and Ibuprofen: the Influence of Body Composition, Formulation and Feeding in Healthy Adult Volunteers.

Authors:  James D Morse; Ioana Stanescu; Hartley C Atkinson; Brian J Anderson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2022-04-02       Impact factor: 2.569

8.  An integrated population pharmacokinetic meta-analysis of propofol in morbidly obese and nonobese adults, adolescents, and children.

Authors:  J Diepstraten; V Chidambaran; S Sadhasivam; H J Blussé van Oud-Alblas; T Inge; B van Ramshorst; E P A van Dongen; A A Vinks; C A J Knibbe
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-09-11

Review 9.  Pharmacokinetic-Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance.

Authors:  Eva Germovsek; Charlotte I S Barker; Mike Sharland; Joseph F Standing
Journal:  Clin Pharmacokinet       Date:  2019-01       Impact factor: 5.577

Review 10.  Clinical Pharmacokinetics and Pharmacodynamics of Propofol.

Authors:  Marko M Sahinovic; Michel M R F Struys; Anthony R Absalom
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.